This has been attributed to the potential of LINK-A expression to enhance the degradation of the antigen peptide-loading complex and the intrinsic tumor suppressors Rb and p53 interfering with tumor antigenicity and tumor’s intrinsic suppression capacity (199). The gene discussed is TP53; the disease is neoplasm.